Mon. 11/08 - The Messy Legacy of Emily Dickinson and Her Favorite Cake
Cool Stuff Daily
Reggie Risseeuw and Marques Pfaff
4.6 • 739 Ratings
🗓️ 8 November 2021
⏱️ 17 minutes
🧾️ Download transcript
Summary
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Ready to launch your business? Get started with the commerce platform made for entrepreneurs. |
| 0:04.8 | Shopify is specially designed to help you start, run and grow your business with easy customizable themes that let you build your brand. |
| 0:12.5 | Marketing tools that get your products out there. Integrated shipping solutions that actually save you time. |
| 0:17.5 | From startups to scaleups, online, in person and on the go shopify is made for |
| 0:22.9 | entrepreneurs like you sign up for your one dollar a month trial at shopify dot com slash setup |
| 0:28.7 | welcome to the codkey ride home for monday November 8th, 2021. I'm Jackson Bird today. |
| 0:42.5 | Another even more promising antiviral pill for COVID-19 has been announced, this time from Pfizer. |
| 0:50.1 | Plus, why adults aren't as good at learning new things as kids are, but is that such a bad thing? |
| 0:56.9 | And the messy legacy of both Emily Dickinson and her favorite cake recipe. |
| 1:03.5 | Here are some of the cool things from the news today. |
| 1:09.0 | So on Thursday, the United Kingdom became the first country to authorize use of Merck's COVID-19 pill, |
| 1:17.0 | and the U.S. Food and Drug Administration is currently reviewing that same one. But now there is |
| 1:22.2 | another pill on the block. Pfizer announced at the end of last week that their antiviral pill called Paxlavid |
| 1:28.9 | was so effective that they stopped their trials early. And this is a common technique when results |
| 1:34.8 | are so undeniably clear, and it was something ordered by an independent group of medical experts. |
| 1:40.3 | Pfizer says that their pill cuts rates of hospitalization and death by nearly 90% in high-risk adults. |
| 1:47.5 | The Phase 2-3 study included 775 unvaccinated high-risk adults, some of whom received the Pfizer-Paxilvid pill three to five days after showing COVID-19 symptoms. |
| 1:59.9 | They were given Paxilvid for five days. |
| 2:02.4 | Those who got the Pfizer pill had an 89% reduction in combined hospitalization and death |
| 2:08.7 | rates. Overall, of those who got the pill less than 1% had symptoms severe enough to require |
| 2:14.5 | hospitalization and not a single participant in that group died. |
| 2:19.3 | Dr. Michael Doolston, Pfizer's chief scientific officer, said, quote, |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Reggie Risseeuw and Marques Pfaff, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Reggie Risseeuw and Marques Pfaff and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.